Evidence map›Paper›PMID 16750543›Full record

ArticleNeuropharmacology2006

Differential targeting and function of alpha2A and alpha2C adrenergic receptor subtypes in cultured sympathetic neurons.

Patricia C Brum, Carl M Hurt, Olga G Shcherbakova, Brian Kobilka, Timothy Angelotti

Abstract readComparative Study
In one paragraph

Article in Neuropharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The amyloid precursor protein modulates αFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Patricia C Brum *Laboratório de Fisiologia do Exercício, Escola de Educação Física e Esporte, Universidade de Sao Paulo, Av. Prof. Mello Moraes 65, 05508-900 Sao Paulo, SP, Brazil.
Carl M Hurt *Department of Molecular and Cellular Physiology, Stanford University Medical School, 157 Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.
Olga G ShcherbakovaDepartment of Molecular and Cellular Physiology, Stanford University Medical School, 157 Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.
Brian KobilkaDepartment of Molecular and Cellular Physiology, Stanford University Medical School, 157 Beckman Center, 279 Campus Drive, Stanford, CA 94305, USA.
Timothy AngelottiDepartment of Anesthesia, Stanford University Medical School, Stanford, CA 94305, USA.
Stanford University · USUniversidade de São Paulo · BR

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007365 · NIGMS · STANFORD UNIVERSITY · PI CHUA, KATRIN F · 1985 to 2021
$33.8M
Sympathetic Neuron alpha2 Adrenoceptor Structure/FunctionK08NS050654 · NINDS · STANFORD UNIVERSITY · PI ANGELOTTI, TIMOTHY P · 2006 to 2010
$884k
NIGMS NIH HHS GM07365NIGMS NIH HHS T32 GM007365NINDS NIH HHS K08 NS050654
6 · The paper itself

Abstract

Previous research suggested that alpha2A and alpha2C adrenergic receptor (AR) subtypes have overlapping but unique physiological roles in neuronal signaling; however, the basis for these dissimilarities is not completely known. To better understand the observed functional differences between these autoreceptors, we investigated targeting and signaling of endogenously expressed alpha2A and alpha2CARs in cultured sympathetic ganglion neurons (SGN). At Days 1 and 4, alpha2A and alpha2CARs could be readily detected in SGN from wild-type mice. By Day 8, alpha2A ARs were targeted to cell body, as well as axonal and dendritic sites, whereas alpha2C ARs were primarily localized to an intracellular vesicular pool within the cell body and proximal dendritic projections. Expression of synaptic vesicle marker protein SV2 did not differ at Day 8 nor co-localize with either subtype. By Day 16, however, alpha2C ARs had relocated to somatodendritic and axonal sites and, unlike alpha2A ARs, co-localized with SV2 at synaptic contact sites. Consistent with a functional role for alpha2 ARs, we also observed that dexmedetomidine stimulation of cultured SGN more efficiently inhibited depolarization-induced calcium entry into older, compared to younger, cultures. These results provide direct evidence of distinct developmental patterns of endogenous alpha2A and alpha2C AR targeting and function in a native cell system and that maturation of SGN in culture leads to alterations in neuronal properties required for proper targeting. More importantly, the co-localization at Day 16 of alpha2C ARs at sites of synaptic contact may partially explain the differential modulation of neurotransmitter release and responsiveness to action potential frequency observed between alpha2A and alpha2C ARs in SGN.

Indexed as

Analysis of VarianceAnimalsAnimals, NewbornCalciumCell DifferentiationCells, CulturedDopamine beta-HydroxylaseFura-2ImmunohistochemistryMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutMicrotubule-Associated ProteinsNerve Tissue ProteinsNeuronsAdra2a protein, mouseAdra2c protein, mouseCalciumDopamine beta-HydroxylaseFura-2Membrane GlycoproteinsMicrotubule-Associated ProteinsMtap2 protein, mouseNerve Tissue ProteinsReceptors, Adrenergic, alpha-2Sv2a protein, mouse

Identifiers

PMID16750543
PMCPMC4010102
OpenAlexW2036576080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.